PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

NCT02288897 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Inadequate rate of enrollment

Conditions

Cutaneous Melanoma

Interventions

DRUG: PV-10 (10% rose bengal disodium)
DRUG: Dacarbazine, temozolomide or talimogene laherparepvec

Sponsor

Provectus Biopharmaceuticals, Inc.